• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For June 28, 2022

    6/28/22 7:01:08 AM ET
    $AEMD
    $AVAV
    $CGNT
    $EPAC
    Medical/Dental Instruments
    Health Care
    Aerospace
    Industrials
    Get the next $AEMD alert in real time by email

     

    Companies Reporting Before The Bell

    • Jupai Hldgs (NYSE:JP) is projected to report earnings for its first quarter.

    • Enerpac Tool Group (NYSE:EPAC) is expected to report quarterly earnings at $0.28 per share on revenue of $155.10 million.

    • TD Synnex (NYSE:SNX) is expected to report quarterly earnings at $2.65 per share on revenue of $15.29 billion.

    • Cognyte Software (NASDAQ:CGNT) is likely to report quarterly earnings at $0.10 per share on revenue of $112.60 million.

    • Roivant Sciences (NASDAQ:ROIV) is likely to report quarterly loss at $0.32 per share on revenue of $13.35 million.

    Companies Reporting After The Bell

    • LiveOne (NASDAQ:LVO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.36 million.

    • Aethlon Medical (NASDAQ:AEMD) is expected to report quarterly loss at $0.14 per share on revenue of $720.00 thousand.

    • Progress Software (NASDAQ:PRGS) is projected to report quarterly earnings at $0.95 per share on revenue of $146.93 million.

    • AeroVironment (NASDAQ:AVAV) is projected to report quarterly earnings at $0.39 per share on revenue of $135.30 million.

    • Beyond Air (NASDAQ:XAIR) is expected to report earnings for its fourth quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $AVAV
    $CGNT
    $EPAC

    CompanyDatePrice TargetRatingAnalyst
    Enerpac Tool Group Corp.
    $EPAC
    1/16/2026Mkt Perform
    William Blair
    TD SYNNEX Corporation
    $SNX
    1/13/2026$180.00Buy
    Goldman
    AeroVironment Inc.
    $AVAV
    12/19/2025$285.00Overweight
    KeyBanc Capital Markets
    AeroVironment Inc.
    $AVAV
    11/20/2025$391.00Overweight
    Piper Sandler
    AeroVironment Inc.
    $AVAV
    11/18/2025$355.00Outperform
    BNP Paribas Exane
    Progress Software Corporation
    $PRGS
    10/13/2025$57.00Neutral → Buy
    Citigroup
    Cognyte Software Ltd.
    $CGNT
    10/3/2025$14.00Buy
    Roth Capital
    AeroVironment Inc.
    $AVAV
    9/18/2025$300.00Buy
    BofA Securities
    More analyst ratings

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Enerpac Tool Group

    William Blair initiated coverage of Enerpac Tool Group with a rating of Mkt Perform

    1/16/26 8:41:55 AM ET
    $EPAC
    Industrial Machinery/Components
    Technology

    Goldman resumed coverage on TD Synnex with a new price target

    Goldman resumed coverage of TD Synnex with a rating of Buy and set a new price target of $180.00

    1/13/26 9:18:14 AM ET
    $SNX
    Retail: Computer Software & Peripheral Equipment
    Technology

    KeyBanc Capital Markets initiated coverage on AeroVironment with a new price target

    KeyBanc Capital Markets initiated coverage of AeroVironment with a rating of Overweight and set a new price target of $285.00

    12/19/25 8:46:10 AM ET
    $AVAV
    Aerospace
    Industrials

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Gline Matthew bought $49,957 worth of shares (3,315 units at $15.07), increasing direct ownership by 0.02% to 17,287,081 units (SEC Form 4)

    4 - Roivant Sciences Ltd. (0001635088) (Issuer)

    9/18/25 7:28:11 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Gawlick Rainer bought $74,351 worth of shares (1,710 units at $43.48), increasing direct ownership by 3% to 55,544 units (SEC Form 4)

    4 - PROGRESS SOFTWARE CORP /MA (0000876167) (Issuer)

    8/13/25 7:00:25 AM ET
    $PRGS
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Gupta Yogesh K bought $103,194 worth of shares (2,100 units at $49.14), increasing direct ownership by 0.91% to 232,396 units (SEC Form 4)

    4 - PROGRESS SOFTWARE CORP /MA (0000876167) (Issuer)

    7/24/25 7:00:24 AM ET
    $PRGS
    Computer Software: Prepackaged Software
    Technology

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LiveOne (Nasdaq: LVO) to Announce Its Third Quarter Fiscal Year 2026 Financial Results and Highlight Three New Fortune 500 Partnerships Driving B2B Growth

    To Host Investor Webcast on February 12, 2026, at 10:00 am Eastern Time (7:00 am Pacific Time) LOS ANGELES, Feb. 11, 2026 (GLOBE NEWSWIRE) -- LiveOne (NASDAQ:LVO), an award-winning, creator-first music, entertainment, and technology platform, plans to announce its operating and financial results for the third fiscal quarter ended December 31, 2025 ("Q3 Fiscal 2026") and host an investor webcast to discuss the results and provide a business update on Thursday, February 12, 2026 at 10:00 am Eastern Time (7:00 am Pacific Time). To access the call, please use the following information: Third Quarter Fiscal Year 2026 Earnings Conference Call Date:Thursday, February 12, 2026Time:10:00 AM Easte

    2/11/26 8:00:00 AM ET
    $LVO
    Restaurants
    Consumer Discretionary

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025

    Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ21.6 P<0.0001). Brepocitinib demonstrated rapid, deep and sustained improvements across all other efficacy endpoints measured with consistent safety profilePriovant plans to progress CS to a pivotal program with a Phase 3 study starting in calendar year 2026 following engagement with the FDA, representing the third indication with a pivotal program for brepocitinib New Drug Application (NDA) was submitted to the FDA for brepocitinib in dermatomyositis (DM). Topline data from Phase 3 studies in non-infectiou

    2/6/26 7:00:00 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CIO Sukhatme Mayukh exercised 651,558 shares at a strike of $12.68, sold $8,985,003 worth of shares (339,441 units at $26.47) and disposed of $8,261,737 worth of shares (312,117 units at $26.47) (SEC Form 4)

    4 - Roivant Sciences Ltd. (0001635088) (Issuer)

    2/11/26 5:53:22 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CFO Mcdonnell Kevin Patrick sold $235,220 worth of shares (879 units at $267.60) (SEC Form 4)

    4 - AeroVironment Inc (0001368622) (Issuer)

    2/11/26 4:48:49 PM ET
    $AVAV
    Aerospace
    Industrials

    Director Healy Colleen was granted 3,134 shares, increasing direct ownership by 33% to 12,632 units (SEC Form 4)

    4 - ENERPAC TOOL GROUP CORP (0000006955) (Issuer)

    2/9/26 4:39:36 PM ET
    $EPAC
    Industrial Machinery/Components
    Technology

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 1, 2022 - FDA Roundup: July 1, 2022

    For Immediate Release: July 01, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for nominations for consumer representatives to serve on advisory committees and panels for which vacancies currently exist or are expected to occur in the near future. The FDA relies on our many advisory committees to help us

    7/1/22 11:54:25 AM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Roivant Sciences Ltd.

    SCHEDULE 13G/A - Roivant Sciences Ltd. (0001635088) (Subject)

    2/11/26 11:50:03 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Beyond Air Inc.

    424B3 - Beyond Air, Inc. (0001641631) (Filer)

    2/10/26 9:00:32 AM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Beyond Air Inc.

    EFFECT - Beyond Air, Inc. (0001641631) (Filer)

    2/10/26 12:15:23 AM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    Financials

    Live finance-specific insights

    View All

    LiveOne (Nasdaq: LVO) to Announce Its Third Quarter Fiscal Year 2026 Financial Results and Highlight Three New Fortune 500 Partnerships Driving B2B Growth

    To Host Investor Webcast on February 12, 2026, at 10:00 am Eastern Time (7:00 am Pacific Time) LOS ANGELES, Feb. 11, 2026 (GLOBE NEWSWIRE) -- LiveOne (NASDAQ:LVO), an award-winning, creator-first music, entertainment, and technology platform, plans to announce its operating and financial results for the third fiscal quarter ended December 31, 2025 ("Q3 Fiscal 2026") and host an investor webcast to discuss the results and provide a business update on Thursday, February 12, 2026 at 10:00 am Eastern Time (7:00 am Pacific Time). To access the call, please use the following information: Third Quarter Fiscal Year 2026 Earnings Conference Call Date:Thursday, February 12, 2026Time:10:00 AM Easte

    2/11/26 8:00:00 AM ET
    $LVO
    Restaurants
    Consumer Discretionary

    Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025

    Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ21.6 P<0.0001). Brepocitinib demonstrated rapid, deep and sustained improvements across all other efficacy endpoints measured with consistent safety profilePriovant plans to progress CS to a pivotal program with a Phase 3 study starting in calendar year 2026 following engagement with the FDA, representing the third indication with a pivotal program for brepocitinib New Drug Application (NDA) was submitted to the FDA for brepocitinib in dermatomyositis (DM). Topline data from Phase 3 studies in non-infectiou

    2/6/26 7:00:00 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LiveOne (Nasdaq: LVO) Expects $57.9M+ Fiscal 2026 YTD Revenue, $19.9M+ Q3 Fiscal 2026 Revenue, $1.0M+ Q3 Fiscal 2026 Adjusted EBITDA*, up ~200% QoQ

    B2B partnerships across Amazon, YouTube, Spotify, Apple, Paramount, YouTube, DAX, TextNow, Telly and AI partners Listener.com and Intuizi continue to drive growth Anticipates launching three Fortune 500 partnerships by year-end across carrier, retail, and TV100+ potential partnerships in the pipelineAchieves 52% YoY OpEx reduction; targeting a 34% YoY headcount reduction ($4M - $5M in savings) by year-end through AI-driven cost optimizationPaid off $2.5M of debt LOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- LiveOne (NASDAQ:LVO), an award-winning, creator-first music, entertainment, and technology platform, announced today certain anticipated financial results for its third fiscal quarter

    2/5/26 8:00:00 AM ET
    $LVO
    Restaurants
    Consumer Discretionary

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    Leadership Updates

    Live Leadership Updates

    View All

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    Hyve Solutions Announces Leadership Transition

    Jerry Kagele Named President; Steve Ichinaga Transitions to Advisory Role After 15 Years Leading Hyperscale Infrastructure Pioneer Hyve Solutions Corporation, a wholly owned subsidiary of TD SYNNEX Corporation (NYSE:SNX) and a leader in the design to worldwide deployment of hyperscale digital infrastructures, today announced that Jerry Kagele has been named President of Hyve Solutions. Kagele succeeds Steve Ichinaga, who is transitioning to an advisory role after four decades of service at TD SYNNEX, including the last 15 years as the founding executive of Hyve Solutions. This planned leadership transition positions the company for continued growth and seamless operational continuity. I

    1/27/26 5:00:00 PM ET
    $SNX
    Retail: Computer Software & Peripheral Equipment
    Technology

    AeroVironment Hires Milancy Harris as Vice President and Chief Security Officer

    AeroVironment, Inc. ("AV") (NASDAQ:AVAV) today announced that Milancy Harris has joined the company as Vice President and Chief Security Officer (CSO). In this role, Harris will lead AV's integrated, enterprise-wide security strategy—strengthening the company's ability to protect its people, programs, technologies, and customers across a rapidly expanding mission portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205926285/en/Milancy Harris joins AeroVironment as Vice President and Chief Security Officer, bringing years of national security experience to strengthen protection of AV's people, programs, and mission. "Mila

    12/5/25 8:34:00 AM ET
    $AVAV
    Aerospace
    Industrials

    $AEMD
    $AVAV
    $CGNT
    $EPAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Roivant Sciences Ltd.

    SC 13G/A - Roivant Sciences Ltd. (0001635088) (Subject)

    11/14/24 4:31:06 PM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Enerpac Tool Group Corp.

    SC 13G/A - ENERPAC TOOL GROUP CORP (0000006955) (Subject)

    11/14/24 1:28:29 PM ET
    $EPAC
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G filed by Enerpac Tool Group Corp.

    SC 13G - ENERPAC TOOL GROUP CORP (0000006955) (Subject)

    11/13/24 4:05:21 PM ET
    $EPAC
    Industrial Machinery/Components
    Technology